OKYO PHARMA LTD SP.ADR/65 (OK10) — Net Asset Momentum
OKYO PHARMA LTD SP.ADR/65 (OK10) recorded a net asset momentum of 5.6% as of March 2025, with net assets of €-5.55 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is OKYO PHARMA LTD SP.ADR/65's equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
OKYO PHARMA LTD SP.ADR/65 Net Asset Momentum (2022–2025)
This chart tracks OKYO PHARMA LTD SP.ADR/65's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +5.6%, with net assets of €-5.55 Million EUR as of March 2025. Read total liabilities of OKYO PHARMA LTD SP.ADR/65 for a breakdown of total debt and financial obligations.
Annual Net Asset History for OKYO PHARMA LTD SP.ADR/65 (2022–2025)
The table below shows the complete annual net asset history for OKYO PHARMA LTD SP.ADR/65 from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of OKYO PHARMA LTD SP.ADR/65.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-5.55 Million | €3.68 Million | €9.23 Million | ▲ +5.6% |
| 2024 | €-5.88 Million | €1.54 Million | €7.42 Million | ▼ -186.4% |
| 2023 | €-2.05 Million | €5.20 Million | €7.26 Million | ▼ -169.7% |
| 2022 | €2.95 Million | €4.30 Million | €1.35 Million | — |